Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Charles River Laboratories
CRL
$14.3B
| $22.8M | 0.04% |
201,099
+192,669
| +2,286% | +$24.1M |
|
652
BJ's Restaurants
BJRI
$1.43B
| $22.7M | 0.04% |
449,660
+242,859
| +117% | +$14.6M |
|
653
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.79B
| $22.7M | 0.04% |
+214,100
| New | +$29.9M |
|
654
PUT
GE Aerospace
GE
$355B
| $22.7M | 0.04% |
625,986
+269,737
| +76% | +$12.2M |
|
655
Ameren
AEE
$29.7B
| $22.7M | 0.04% |
347,383
+235,546
| +211% | +$15.7M |
|
656
Lumentum
LITE
$74.5B
| $22.6M | 0.04% |
538,928
-248,407
| -32% | -$12.2M |
|
657
CALL
Costco
COST
$431B
| $22.6M | 0.04% |
110,900
+82,800
| +295% | +$18.5M |
|
|
NBIS
658
Nebius Group N.V.
NBIS
$57.3B
| $22.6M | 0.04% |
825,559
+393,390
| +91% | +$11.5M |
|
|
BDN
659
Brandywine Realty Trust
BDN
$548M
| $22.6M | 0.04% |
1,754,066
-133,987
| -7% | -$1.89M |
|
660
Target
TGT
$77.2B
| $22.5M | 0.04% |
340,464
+82,045
| +32% | +$6.31M |
|
661
Upbound Group
UPBD
$1.12B
| $22.4M | 0.04% |
1,385,377
+1,339,742
| +2,936% | +$19.5M |
|
662
Qiagen
QGEN
$8.63B
| $22.4M | 0.04% |
613,770
+388,738
| +173% | +$14.4M |
|
663
Collegium Pharmaceutical
COLL
$848M
| $22.4M | 0.03% |
1,305,001
+1,169,537
| +863% | +$20M |
|
|
ENDP
664
DELISTED
Endo International plc
ENDP
| $22.4M | 0.03% |
3,068,467
+589,387
| +24% | +$8.09M |
|
665
KBR
KBR
$4.75B
| $22.4M | 0.03% |
1,474,507
-651,202
| -31% | -$12.2M |
|
666
Cooper Companies
COO
$14.8B
| $22.3M | 0.03% |
351,048
+276,996
| +374% | +$17.9M |
|
|
MIK
667
DELISTED
Michaels Stores, Inc
MIK
| $22.3M | 0.03% |
1,649,187
+1,268,989
| +334% | +$20.1M |
|
668
Dolby
DLB
$6.19B
| $22.3M | 0.03% |
360,225
+138,955
| +63% | +$9.35M |
|
|
UCB
669
United Community Banks
UCB
$4.27B
| $22.3M | 0.03% |
1,037,312
+536,075
| +107% | +$13.2M |
|
670
ABM Industries
ABM
$2.75B
| $22.1M | 0.03% |
689,460
+142,470
| +26% | +$4.36M |
|
671
uniQure
QURE
$3.29B
| $22.1M | 0.03% |
767,098
+283,373
| +59% | +$7.89M |
|
672
Bruker
BRKR
$8.68B
| $22M | 0.03% |
740,643
+220,482
| +42% | +$6.96M |
|
673
Hanover Insurance
THG
$7.92B
| $22M | 0.03% |
188,500
-39,519
| -17% | -$4.43M |
|
674
PUT
State Street Technology Select Sector SPDR ETF
XLK
$117B
| $21.9M | 0.03% |
+707,800
| New | +$23.9M |
|
|
CHK
675
DELISTED
Chesapeake Energy Corporation
CHK
| $21.9M | 0.03% |
52,093
+15,647
| +43% | +$10.8M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.